keyword
https://read.qxmd.com/read/38642595/subcutaneous-oxytocin-injection-reduces-heat-pain-a-randomized-controlled-trial
#1
JOURNAL ARTICLE
Benedetta Albinni, Marisa Zimmerman, Jacob Ross, Leyla Ozdoyuran, Vincent Alasha, Nathaniel M Schuster, Engy Said, Laura Case
Oxytocin 1 is a neuropeptide broadly implicated in social relationships and behavior. OT also exerts antinociceptive and pain-reducing effects in both humans and rodents. Recent research in rodents demonstrates that these effects can be peripheral and local. In human studies, intravenous OT has reduced visceral pain and subcutaneous injection of OT has reduced postsurgical pain. However, the local effects of subcutaneous OT on experimental pain have not been studied. We conducted a two-session crossover study during which healthy adults received a subcutaneous injection of synthetic OT (4mcg/2ml) or saline placebo (isotonic saline 2ml), in a randomized and double-blinded manner...
April 18, 2024: Journal of Pain
https://read.qxmd.com/read/38638417/effects-of-systemic-pretreatment-with-the-naaladase-inhibitor-2-pmpa-on-oral-methamphetamine-reinforcement-in-c57bl-6j-mice
#2
JOURNAL ARTICLE
Elissa K Fultz, Andrea Y T Nei, Joyce C Chi, Jacqueline N Lichter, Karen K Szumlinski
INTRODUCTION: Repeated exposure to methamphetamine (MA) in laboratory rodents induces a sensitization of glutamate release within the corticoaccumbens pathway that drives both the rewarding and reinforcing properties of this highly addictive drug. Such findings argue the potential for pharmaceutical agents inhibiting glutamate release or its postsynaptic actions at glutamate receptors as treatment strategies for MA use disorder. One compound that may accomplish both of these pharmacological actions is the N -acetylated-alpha-linked-acidic dipeptidase (NAALADase) inhibitor 2-(phosphonomethyl)pentanedioic acid (2-PMPA)...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38618640/recurrent-psychotic-episodes-induced-by-synthetic-cathinones-in-a-monozygotic-twin-with-drug-addiction-a-case-report
#3
Vsevolod V Severtsev, Albina A Budanova
We have described a clinical case of psychotic disorder induced by synthetic cathinones in one drug-addicted monozygotic twin. This clinical case is unique, because it offers the opportunity to observe many features of the singularity of the dependence syndrome in twin brothers: drug choice; motivation to use drugs; and the development of multiple, long-lasting psychoses in one of the brothers. We pursued a twelve-month follow-up of this case. The case substantiates the paucity of a fundamental understanding of mental disorders and highlights the importance of further research into the clinical features of drug-induced psychoses, especially those induced by novel psychoactive substances such as synthetic cathinones...
December 22, 2023: Consort Psychiatr
https://read.qxmd.com/read/38611824/analgesic-peptides-from-natural-diversity-to-rational-design
#4
REVIEW
Katarzyna Gach-Janczak, Monika Biernat, Mariola Kuczer, Anna Adamska-Bartłomiejczyk, Alicja Kluczyk
Pain affects one-third of the global population and is a significant public health issue. The use of opioid drugs, which are the strongest painkillers, is associated with several side effects, such as tolerance, addiction, overdose, and even death. An increasing demand for novel, safer analgesic agents is a driving force for exploring natural sources of bioactive peptides with antinociceptive activity. Since the G protein-coupled receptors (GPCRs) play a crucial role in pain modulation, the discovery of new peptide ligands for GPCRs is a significant challenge for novel drug development...
March 29, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38588756/the-fentanyl-specific-antibody-fenab024-can-shield-against-carfentanil-effects
#5
JOURNAL ARTICLE
Katharina Urban, Anastasia Gkeka, Monica Chandra, Dennis Greiner, Selina Pollich, Sandra Ruf, Yosip Kelemen, Tom Sundermann, Marco Pravetoni, Carly Baehr, C Erec Stebbins, F Nina Papavasiliou, Joseph P Verdi
The surge in opioid-related deaths, driven predominantly by fentanyl and its synthetic derivatives, has become a critical public health concern, which is particularly evident in the United States. While the situation is less severe in Europe, the European Monitoring Centre for Drugs and Drug Addiction reports a rise in drug overdose deaths, with emerging concerns about the impact of fentanyl-related molecules. Synthetic opioids, initially designed for medical use, have infiltrated illicit markets due to their low production costs and high potency, with carfentanil posing additional threats, including potential chemical weaponization...
April 6, 2024: Toxicology Letters
https://read.qxmd.com/read/38568147/insights-into-primary-care-physicians-detection-intervention-and-management-of-patients-with-substance-use-disorders-in-egypt
#6
JOURNAL ARTICLE
Safaa M El-Zoghby, Reda Madroumi, Stephanie Kewley, Marie Claire Van Hout
Egypt is experiencing an increasing drug problem (cannabis, heroin, amphetamines, pharmaceutical opioids, synthetic cannabinoids). Whilst harm reduction and addiction treatment are provided by government and non-governmental organizations in Egypt, very little is known about physicians experience of handling patient substance use and substance use disorder (SUD) in primary care. A cross-sectional national study of 392 Egyptian Family Physicians (FPs) & General Practitioners (GPs) explored their knowledge, attitude and professional practice regarding management of SUD in primary care, as a first step toward identifying professional development support needs and informing general practice...
April 3, 2024: Journal of Ethnicity in Substance Abuse
https://read.qxmd.com/read/38558723/methadone-withdrawal-induced-psychosis-a-case-report
#7
Oluwaseun Oke, Marta B Sekh, Bamidele O Johnson, Samuel Adeyemo
Methadone is a synthetic full µ-opioid receptor agonist and N-methyl-D-aspartate antagonist given to patients who have recently stopped using illicit opioids or are tapering off chronic opioid pain medication. Maintenance treatment with methadone is today the most widespread and effective way to treat opiate addiction, which achieves abstinence, decreases morbidity and mortality, improves quality of life, and reduces crime genesis, among other benefits. It is also approved by the Food and Drug Administration for treating moderate-to-severe pain that remains unresponsive to nonopioid medications...
February 2024: Curēus
https://read.qxmd.com/read/38548662/-spice-use-motivations-experiences-and-repercussions-among-veterans-of-the-united-states-armed-forces
#8
JOURNAL ARTICLE
John Stogner, Julie Marie Baldwin, Amelia Wiercioch
BACKGROUND AND OBJECTIVES: The potential for synthetic cannabinoids (SCs) to function as an alternative to marijuana without the same risk of a positive urinalyses led to claims of pervasive military SC use. Case studies confirm use among veterans, but no study has adequately explored SC use in the military using detailed interview data. METHODS: Interviews (1-2 h) were conducted with 318 justice-involved veterans. Recruitment was attempted with all participants in eight veterans treatment courts in three U...
March 28, 2024: Substance Use & Misuse
https://read.qxmd.com/read/38546531/characterization-of-the-neurochemical-and-behavioral-effects-of-the-phenethylamine-2-cl-4-5-mdma-in-adolescent-and-adult-male-rats
#9
JOURNAL ARTICLE
Gessica Piras, Cristina Cadoni, Francesca Caria, Nicholas Pintori, Enrica Spano, Maksims Vanejevs, Anastasija Ture, Graziella Tocco, Nicola Simola, Maria Antonietta De Luca
BACKGROUND: The proliferation of Novel Psychoactive Substances (NPS) in the drug market raises concerns about uncertainty on their pharmacological profile and the health hazard linked to their use. Within the category of synthetic stimulant NPS, the phenethylamine 2-Cl-4,5-methylenedioxymethamphetamine (2-Cl-4,5-MDMA) has been linked to severe intoxication requiring hospitalization. Thereby, the characterization of its pharmacological profile is urgently warranted. METHODS: By in vivo brain microdialysis in adolescent and adult male rats we investigated the effects of 2-Cl-4,5-MDMA on dopamine (DA) and serotonin (5-HT) neurotransmission in two brain areas critical for the motivational and reinforcing properties of drugs, the nucleus accumbens (NAc) shell and the medial prefrontal cortex (mPFC)...
March 28, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38494150/systematic-identification-of-a-synthetic-lethal-interaction-in-brain-metastatic-lung-adenocarcinoma
#10
JOURNAL ARTICLE
Jin Woo Moon, Beom-Jin Hong, Seon-Kyu Kim, Min-Seok Park, Hohyeon Lee, JiWon Lee, Mi-Young Kim
Metastatic lung adenocarcinoma (LuAC) presents a significant clinical challenge due to the short latency and the lack of efficient treatment options. Therefore, identification of molecular vulnerabilities in metastatic LuAC holds great importance in the development of therapeutic drugs against this disease. In this study, we performed a genome-wide siRNA screening using poorly and highly brain-metastatic LuAC cell lines. Using this approach, we discovered that compared to poorly metastatic LuAC (LuAC-Par) cells, brain-metastatic LuAC (LuAC-BrM) cells exhibited a significantly higher vulnerability to c-FLIP (an inhibitor of caspase-8)-depletion-induced apoptosis...
March 15, 2024: Cancer Letters
https://read.qxmd.com/read/38467490/structural-and-functional-perspectives-on-interactions-between-synthetic-cathinones-and-monoamine-transporters
#11
JOURNAL ARTICLE
Vy T Nguyen, Alan C Harris, Jose M Eltit
Synthetic cathinone derivatives comprise a family of psychoactive compounds structurally related to amphetamine. Over the last decade, clandestine chemists have synthesized a consistent stream of innovative cathinone derivatives to outpace governmental regulatory restrictions. Many of these unregulated substances are produced and distributed as designer drugs. Two of the principal chemical scaffolds exploited to expand the synthetic cathinone family are methcathinone and α-pyrrolidinopentiophenone (or α-pyrrolidinovalerophenone, α-PVP)...
2024: Advances in Pharmacology
https://read.qxmd.com/read/38432046/immune-and-glial-cell-alterations-in-the-rat-brain-after-repeated-exposure-to-the-synthetic-cannabinoid-jwh-018
#12
JOURNAL ARTICLE
Nicholas Pintori, Rafaela Mostallino, Enrica Spano, Valeria Orrù, Maria Grazia Piras, Maria Paola Castelli, Maria Antonietta De Luca
The use of synthetic cannabinoid receptor agonists (SCRAs) poses major psychiatric risks. We previously showed that repeated exposure to the prototypical SCRA JWH-018 induces alterations in dopamine (DA) transmission, abnormalities in the emotional state, and glial cell activation in the mesocorticolimbic DA circuits of rats. Despite growing evidence suggesting the relationship between substance use disorders (SUD) and neuroinflammation, little is known about the impact of SCRAs on the neuroimmune system. Here, we investigated whether repeated JWH-018 exposure altered neuroimmune signaling, which could be linked with previously reported central effects...
February 26, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38382631/morphinan-evolution-the-impact-of-advances-in-biochemistry-and-molecular-biology
#13
JOURNAL ARTICLE
Keita Kajino, Akihisa Tokuda, Tsuyoshi Saitoh
Morphinan-based opioids, derived from natural alkaloids like morphine, codeine, and thebaine, have long been pivotal in managing severe pain. However, their clinical utility is marred by significant side effects and high addiction potential. This review traces the evolution of the morphinan scaffold in light of advancements in biochemistry and molecular biology, which have expanded our understanding of opioid receptor pharmacology. We explore the development of semi-synthetic and synthetic morphinans, their receptor selectivity, and the emergence of biased agonism as a strategy to dissociate analgesic properties from undesirable effects...
February 21, 2024: Journal of Biochemistry
https://read.qxmd.com/read/38375666/xylazine-and-adulterants-in-the-evolving-drug-supply-urgent-call-for-responsive-education-models
#14
JOURNAL ARTICLE
Raagini Jawa, Stephen Murray, Samantha Blakemore, Alicia S Ventura, Tavita Hristova, Alexa Wilder, Margaret Shang, Colleen LaBelle
Novel adulterants and synthetic substances are rapidly infiltrating the US drug supply causing new clinical harms. There is an urgent need for responsive education and training to address these evolving harms and mitigate new risks. Since 2020, xylazine, a veterinary tranquilizer, has become increasingly common in the illicit opioid supply, especially alongside fentanyl. Training and technical assistance (TTA) programs employing an adaptive model can quickly disseminate emerging information and provide the tools to respond effectively...
February 20, 2024: Subst Use Addctn J
https://read.qxmd.com/read/38310293/impact-of-harm-minimization-interventions-on-reducing-blood-borne-infection-transmission-and-some-injecting-behaviors-among-people-who-inject-drugs-an-overview-and-evidence-gap-mapping
#15
REVIEW
Fernanda S Tonin, Filipa Alves da Costa, Fernando Fernandez-Llimos
BACKGROUND: This study aimed to synthetize the evidence on the effectiveness of harm minimization interventions on reducing blood-borne infection transmission and injecting behaviors among people who inject drugs (PWID) through a comprehensive overview of systematic reviews and evidence gap mapping. METHODS: A systematic review was conducted with searches in PubMed and Scopus to identify systematic reviews assessing the impact of interventions aimed at reducing the harms associated with injectable drug use...
February 4, 2024: Addiction Science & Clinical Practice
https://read.qxmd.com/read/38275646/trihexyphenidyl-alters-its-host-s-metabolism-neurobehavioral-patterns-and-gut-microbiome-feedback-loop-the-modulating-role-of-anacyclus-pyrethrum
#16
JOURNAL ARTICLE
Abdelmounaim Baslam, Hajar Azraida, Rachida Aboufatima, Mohamed Ait-El-Mokhtar, Ilham Dilagui, Samia Boussaa, Abderrahman Chait, Marouane Baslam
Trihexyphenidyl (THP)-a synthetic anticholinergic medication used to manage parkinsonism and extrapyramidal symptoms-has gained significant clinical recognition. However, there is a critical gap in understanding its withdrawal effects. This study investigates the intricate interplay between gut microbiota and oxidative stress during THP withdrawal. Furthermore, it explores the therapeutic potential of Anacyclus pyrethrum (AEAP) for alleviating the associated adverse effects. This comprehensive research combines behavioral tests, biochemical analysis, gut microbiome assessment utilizing matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), and oxidative stress measures...
December 21, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38260445/enabling-systemic-identification-and-functionality-profiling-for-cdc42-homeostatic-modulators
#17
Satyaveni Malasala, Fereshteh Azimian, Yan-Hua Chen, Jeffery L Twiss, Christi Boykin, Shayan Nik Akhtar, Qun Lu
UNLABELLED: Homeostatic modulation is pivotal in modern therapeutics. However, the discovery of bioactive materials to achieve this functionality is often random and unpredictive. Here, we enabled a systemic identification and functional classification of chemicals that elicit homeostatic modulation of signaling through Cdc42, a classical small GTPase of Ras superfamily. Rationally designed for high throughput screening, the capture of homeostatic modulators (HMs) along with molecular re-docking uncovered at least five functionally distinct classes of small molecules...
January 8, 2024: bioRxiv
https://read.qxmd.com/read/38215750/a-comprehensive-clinically-informed-map-of-dependencies-in-cancer-cells-and-framework-for-target-prioritization
#18
JOURNAL ARTICLE
Clare Pacini, Emma Duncan, Emanuel Gonçalves, James Gilbert, Shriram Bhosle, Stuart Horswell, Emre Karakoc, Howard Lightfoot, Ed Curry, Francesc Muyas, Monsif Bouaboula, Chandra Sekhar Pedamallu, Isidro Cortes-Ciriano, Fiona M Behan, Lykourgos-Panagiotis Zalmas, Andrew Barthorpe, Hayley Francies, Steve Rowley, Jack Pollard, Pedro Beltrao, Leopold Parts, Francesco Iorio, Mathew J Garnett
Genetic screens in cancer cell lines inform gene function and drug discovery. More comprehensive screen datasets with multi-omics data are needed to enhance opportunities to functionally map genetic vulnerabilities. Here, we construct a second-generation map of cancer dependencies by annotating 930 cancer cell lines with multi-omic data and analyze relationships between molecular markers and cancer dependencies derived from CRISPR-Cas9 screens. We identify dependency-associated gene expression markers beyond driver genes, and observe many gene addiction relationships driven by gain of function rather than synthetic lethal effects...
February 12, 2024: Cancer Cell
https://read.qxmd.com/read/38180867/substance-use-overdose-deaths-among-black-and-indigenous-women-in-wisconsin-a-review-of-death-certificate-data-from-2018-to-2020
#19
JOURNAL ARTICLE
Alexa A Lopez, Jeneile M Luebke, Ryan Redner, Hanan Abusbaitan, Sergey Tarima
OBJECTIVES: We are in the midst of an overdose epidemic that has grown during the concurrent COVID-19 pandemic. In Wisconsin, overdose deaths increased 11-fold from 2000 to 2020, with over 1200 deaths in 2020. Because of disparities in substance use initiation, relapse, and treatment success among racially minoritized women, this study's purpose was to investigate overdose death rates among Black and Indigenous women in Wisconsin from 2018 to 2020. METHODS: Overdose death rates were examined under the following parameters: sex, race (Black, Indigenous, White), age, year, and manner of death...
January 5, 2024: Journal of Addiction Medicine
https://read.qxmd.com/read/38168240/levodopa-reduces-consumption-of-multiple-classes-of-addictive-substances-in-rats
#20
Ryan D Farero, Nathan A Holtz, Suhjung J Lee, Lauren C Kruse, Jeremy J Clark, Paul E M Phillips
Dopamine transmission is implicated in aberrant behaviors associated with substance use disorders. Previous research revealed a causal link between excessive drug consumption and the loss of dopamine signaling to stimuli associated with psychostimulant use. The emerging change in dopamine signaling is specific to stimuli associated with the substance rather than the pharmacological properties of the drug itself. Because the change in dopamine signaling was specific to the associated stimuli and not the pharmacological properties of the substance, we examined if treatment with the dopamine precursor, L-DOPA, alters alcohol and opioid self-administration...
December 15, 2023: bioRxiv
keyword
keyword
169228
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.